Leveraging MRD to Develop Personalized Treatment Options
Time: 4:40 pm
day: Day Two PM
Details:
- Integrating ctDNA, MRD, and real-world data to define patient populations and improve outcomes
- Developing algorithms to improve patient stratification
- Insights from tumor-informed and tumor-naive testing
